335 related articles for article (PubMed ID: 24993621)
21. Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution.
Maruyama R; Shoji F; Okamoto T; Miyamoto T; Miyake T; Nakamura T; Ikeda J; Asoh H; Yamaguchi M; Yoshino I; Ichinose Y
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1587-92. PubMed ID: 15173711
[TBL] [Abstract][Full Text] [Related]
22. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
Wang CY; Huang MS; Huang MH; Lee HC; Hsu HS
J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic invasion is a more significant prognostic factor than visceral pleural invasion in non-small cell lung cancer with tumours of 3 cm or less.
Moon Y; Park JK; Lee KY; Sung SW
Respirology; 2017 Aug; 22(6):1179-1184. PubMed ID: 28382791
[TBL] [Abstract][Full Text] [Related]
25. Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer.
Kudo Y; Saji H; Shimada Y; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Lung Cancer; 2013 Aug; 81(2):187-93. PubMed ID: 23664031
[TBL] [Abstract][Full Text] [Related]
26. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
[TBL] [Abstract][Full Text] [Related]
27. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
[TBL] [Abstract][Full Text] [Related]
28. Non-small-cell lung cancer prognosis using carcinoembryonic antigen levels in pleural lavage fluid.
Tsutani Y; Yamashita Y; Misumi K; Ikeda T; Miyata Y; Okada M
Eur J Cardiothorac Surg; 2012 Nov; 42(5):e96-101. PubMed ID: 22906597
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Chest; 2008 Mar; 133(3):662-9. PubMed ID: 17925418
[TBL] [Abstract][Full Text] [Related]
30. Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker.
Sayar A; Turna A; Solak O; Kiliçgün A; Urer N; Gürses A
Ann Thorac Surg; 2004 Feb; 77(2):421-5. PubMed ID: 14759409
[TBL] [Abstract][Full Text] [Related]
31. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
32. T1aN0M0 and T1bN0M0 non-small cell lung cancer: a retrospective study of the prognosis.
Zhang Z; Wang A; Zhan Z; Sun L; Chen K; Wang C
Thorac Cardiovasc Surg; 2014 Mar; 62(2):109-16. PubMed ID: 23225513
[TBL] [Abstract][Full Text] [Related]
33. Very important histopathological factors in patients with resected non-small cell lung cancer: necrosis and perineural invasion.
Kiliçgün A; Turna A; Sayar A; Solak O; Urer N; Gürses A
Thorac Cardiovasc Surg; 2010 Mar; 58(2):93-7. PubMed ID: 20333571
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with recurrence in patients with curatively resected stage I-II lung cancer.
Koo HK; Jin SM; Lee CH; Lim HJ; Yim JJ; Kim YT; Yang SC; Yoo CG; Han SK; Kim JH; Shim YS; Kim YW
Lung Cancer; 2011 Aug; 73(2):222-9. PubMed ID: 21168237
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less.
Kobayashi N; Toyooka S; Soh J; Ichimura K; Yanai H; Suehisa H; Ichihara S; Yamane M; Aoe M; Sano Y; Date H
J Thorac Oncol; 2007 Sep; 2(9):808-12. PubMed ID: 17805057
[TBL] [Abstract][Full Text] [Related]
36. Single T factors predict survival of patients with resected stage-IIB non-small-cell lung cancers.
Suzuki M; Yoshida S; Moriya Y; Hoshino H; Mizobuchi T; Okamoto T; Yoshino I
Eur J Cardiothorac Surg; 2011 May; 39(5):745-8. PubMed ID: 20850983
[TBL] [Abstract][Full Text] [Related]
37. Validation of the 7th TNM classification for non-small cell lung cancer: a retrospective analysis on prognostic implications for operated node-negative cases.
Bergman P; Brodin D; Lewensohn R; de Petris L
Acta Oncol; 2013 Aug; 52(6):1189-94. PubMed ID: 23215828
[TBL] [Abstract][Full Text] [Related]
38. Tumor size does not have prognostic significance in stage Ia NSCLC.
Yanagi S; Sugiura H; Morikawa T; Kaji M; Okushiba S; Kondo S; Katoh H
Anticancer Res; 2000; 20(2B):1155-8. PubMed ID: 10810413
[TBL] [Abstract][Full Text] [Related]
39. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
[TBL] [Abstract][Full Text] [Related]
40. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
Moon Y; Lee KY; Park JK
World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
